ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

Time to be Optimistic

Time to be Optimistic Hansavivek GLAXO LABORATORIES has commenced production of Ibuprofen and Sotalal at its new bulk drug factory at Ankleshwar in Gujarat. The company has received letters of intent for the manufacture there of Griseofulvin, an antifungal antibiotic, and Cephalexin, a cephalosprin. It has also sought approval of the government for manufacture of Ranitidin, an advanced ami- ulcerant which was discovered by Glaxo, UK. Know-how for all these three products will be provided free of cost by the UK firm. In response to company's representations made in the past years, government has endorsed higher licensed capacities for three of the food products manufactured at Aligarh, but its application for permission for flexibility to produce other forms of milk foods there is stilt pending.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now


(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top